The presence of coronary artery calcium (CAC) is an important marker of atherosclerosis burden and the evaluation of the extent of CAC may be used in clinical management of asymptomatic patients at intermediate risk of coronary artery disease (CAD).1 The presence of high CAC score is associated with higher probability of significant obstructive CAD and is also a strong predictor for risk assessment of hard cardiovascular events, such as myocardial infarction and sudden cardiac death.2 Patients with values of CAC score > 400 are at higher risk of adverse cardiac events and need more advanced testing.3 On the other hand, myocardial perfusion imaging (MPI) is a useful noninvasive method for diagnostic and prognostic evaluation of patients with suspected CAD.4 The introduction of hybrid imaging as single photon emission computed tomography (SPECT)/computed tomography (CT) and positron emission tomography/CT allows to perform morphological and functional imaging in a same study session with a comfortable accuracy.5 A combined evaluation of functional and structural abnormalities allows to improve the detection of obstructive CAD and to better stratify patients at low-intermediate risk of CAD.6 Previous studies demonstrated that the major predictors of events in patients with suspected CAD are the extent of atherosclerotic burden, assessed by CAC, and the extent and severity of stress-induced myocardial ischemia, as assessed by MPI.7 The evaluation of CAC content in association with myocardial perfusion may improve specificity and positive predictive value for the detection of CAD, in particular in patients with a CAC score value more than zero.8 However, subclinical atherosclerosis may be also frequently present in patients with normal myocardial perfusion and a normal MPI does not necessarily exclude significant coronary stenosis.9,10
In the current issue of the Journal, Yokota et al.11 assessed the association between high values of CAC score and increased rates of referral for invasive coronary angiography (ICA) in patients with suspected CAD and normal myocardial perfusion at SPECT imaging. In a study population of 2286 patients with suspected CAD undergoing stress MPI for evaluation of both perfusion data and CAC content by SPECT/CT, the authors found a relationship between CAC score and rates of referral for ICA. Only patients with normal myocardial perfusion were included in the analysis and decision for post-imaging treatment strategy was left to the discretion of the referring physician. In 100 patients undergoing ICA within 60 days after SPECT/CT, rates of referral increased significantly with increasing of CAC score. Only 1% of patients with CAC score 0 underwent ICA, while 11, 7% of patients with CAC score > 400 were referred for ICA. Among these patients, the percentage of obstructive CAD increased with higher CAC score groups. In patients with CAC score > 400, 49% showed obstructive CAD at ICA. To confirm these data, the authors performed a regression analysis, showing that only CAC score > 400 and age were independently associated with referral to ICA. Yokota et al.11 also performed a survival analysis to assess the influence of CAC score and early referral to ICA on cardiac risk events. They demonstrated a significant increase of events with increasing CAC scores, with an incidence of 5, 3%/year for patients with a CAC score > 400. At multivariate Cox regression analysis age, male gender, and CAC score > 100 were independently associated with the occurrence of cardiac events during follow-up. Although early referral to ICA resulted as univariate predictor of events, multivariate analysis showed no significant value in predicting outcome. The authors concluded that CAC scores influence post-imaging clinical decision making with regard to referral for ICA in patients at low-intermediate risk of CAD and with normal MPI.
The use of stress MPI has become one of the most common noninvasive methods for assessing diagnosis and prognosis of patients with suspected CAD.12 Several studies confirmed the prognostic value of this method, which was able to identify patients that may benefit from coronary revascularization procedure. Patients with normal MPI have a very low risk of adverse cardiac events. However, SPECT imaging has some important limitations and may results in a false negative findings in presence of some condition such as balanced multi-vessel CAD and left main disease.13 The prognostic value of CAC score in asymptomatic patients at intermediate risk of CAD and its preliminary use to evaluate the need for subsequent ischemia testing has been widely documented.14,15,16 Other studies assessed the relationship between coronary artery atherosclerosis and presence of stress-induced ischemia at SPECT imaging.17 Quantification of CAC also provides incremental prognostic value in patients with non-significant myocardial perfusion deficit or normal MPI and high CAC score is associated with moderate incidence of severe CAD.18,19,20
One of the major strength of the work proposed by Yokota et al.11 is the correlation between CAC score values, obtained by SPECT/CT, and angiographic data, considering that the relationship between the extent of coronary calcification and the likelihood of significant CAD in patients with normal MPI findings has not been fully clarified and should be not underestimated. The presence of a significant correlation between CAC score and obstructive CAD may offer an opportunity to use CAC scanning in patients with suspected CAD. A recent study demonstrated that in patients with suspected CAD and normal myocardial perfusion CAC score is able to predict a reduced coronary flow reserve, associated with endothelial dysfunction.21 Also in this case, the use of CAC score may help to select the best management and treatment strategy.
The results of CAC scanning may be used in algorithms useful to estimate the likelihood of angiographic CAD and select patients who may benefit from aggressive medical management. The results reported by Yokota et al.11 suggest a potential rule of CAC scanning in the evaluation of subjects with suspected CAD as preliminary to CT-based and/or invasive coronary angiography. However, whether the aggressive management of risk factors and an early invasive strategy induced by CAC scoring data prevents future adverse cardiovascular events, especially in patients with extensive atherosclerotic burden, remains unclear, and future studies are needed to address this issue.
References
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, AmericanCollege of Cardiology Foundation; American Heart Association, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;2010:e50-103.
Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000;86:495-8.
Assante R, Acampa W, Zampella E, Arumugam P, Nappi C, Gaudieri V, et al. Prognostic value of atherosclerotic burden and coronary vascular function in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2017. doi:10.1007/s00259-017-3800-7.
Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, American Heart Association; American Society for Nuclear Cardiology, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.
Bybee KA, Lee J, Markiewicz R, Longmore R, McGhie AI, O’Keefe JH, et al. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol 2010;17:188-96.
Brodov Y, Gransar H, Dey D, Shalev A, Germano G, Friedman JD, et al. Combined quantitative assessment of myocardial perfusion and coronary artery calcium score by hybrid 82Rb PET/CT improves detection of coronary artery disease. J Nucl Med 2015;56:1345-50.
Nappi C, Nicolai E, Daniele S, Acampa W, Gaudieri V, Assante R, et al. Long-term prognostic value of coronary artery calcium scanning, coronary computed tomographic angiography and stress myocardial perfusion imaging in patients with suspected coronary artery disease. J Nucl Cardiol 2016. doi:10.1007/s12350-016-0657-2.
von Ziegler F, Brendel M, Uebleis C, Helbig S, Greif M, Ruemmler J, et al. SPECT myocardial perfusion imaging as an adjunct to coronary calcium score for the detection of hemodynamically significant coronary artery stenosis. BMC Cardiovasc Disord 2012;12:116.
Allam AHA, Thompson RC, Eskander MA, Ali MA, Sadek A, Rowan CJ, et al. Is coronary calcium scoring too late? Total body arterial calcium burden in patients without known CAD and normal MPI. J Nucl Cardiol 2017. doi:10.1007/s12350-017-0925-9.
Schuijf JD, Wijns W, Jukema JW, Atsma DE, de Roos A, Lamb HJ, et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 2006;48:2508-14.
Yokota S, Mouden M, Ottervanger JP, Engbers E, Jager PL, Timmer JR, et al. Coronary calcium score influences referral for invasive coronary angiography after normal myocardial perfusion SPECT. J Nucl Cardiol 2017: 1-11.
Marcassa C, Bax JJ, Bengel F, Hesse B, Petersen CL, Reyes E, European Council of Nuclear Cardiology (ECNC); European Society of Cardiology Working Group 5 (Nuclear Cardiology and Cardiac CT); European Association of Nuclear Medicine Cardiovascular Committee, et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: A position statement. Eur Heart J 2008;29:557-63.
Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007;14:521-8.
Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease. J Nucl Med 2006;47:1107-18.
Schepis T, Gaemperli O, Koepfli P, Namdar M, Valenta I, Scheffel H, et al. Added value of coronary artery calcium score as an adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk population. J Nucl Med 2007;48:1424-30.
Mouden M, Ottervanger JP, Timmer JR, Reiffers S, Oostdijk AH, Knollema S, et al. The influence of coronary calcium score on the interpretation of myocardial perfusion imaging. J Nucl Cardiol 2014;21:368-74.
Matsuo S, Nakajima K, Okuda K, Kinuya S. The relationship between stress-induced myocardial ischemia and coronary artery atherosclerosis measured by hybrid SPECT/CT camera. Ann Nucl Med 2011;25:650-6.
Barros MV, Nunes Mdo C, Braga G, Rabelo DR, Magalhães K, Scaramello F, Siqueira MH. Role of coronary artery calcium score for risk stratification in patients with non significant perfusion defects by myocardial perfusion single photon emission computed tomography. Cardiol J 2015;22:330-5.
Chang SM, Nabi F, Xu J, Peterson LE, Achari A, Pratt CM, Mahmarian JJ. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 2009;54:1872-82.
Yuoness SA, Goha AM, Romsa JG, Akincioglu C, Warrington JC, Datta S, et al. Very high coronary artery calcium score with normal myocardial perfusion SPECT imaging is associated with a moderate incidence of severe coronary artery disease. Eur J Nucl Med Mol Imaging 2015;42:1542-50.
Assante R, Zampella E, Arumugam P, Acampa W, Imbriaco M, Tout D, et al. Quantitative relationship between coronary artery calcium and myocardial blood flow by hybrid rubidium-82 PET/CT imaging in patients with suspected coronary artery disease. J Nucl Cardiol 2017;24:494-501.
Disclosure
The authors have indicated that they have no financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
See related article, doi: 10.1007/s12350-017-1067-9
Rights and permissions
About this article
Cite this article
Assante, R., Klain, M. & Acampa, W. Use of coronary artery calcium scanning as a triage for invasive coronary angiography. J. Nucl. Cardiol. 26, 613–615 (2019). https://doi.org/10.1007/s12350-017-1076-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-017-1076-8